Correction to: European Association of Nuclear Medicine (EANM) response to the proposed ASTRO's framework for radiopharmaceutical therapy curriculum development for trainees.

Dierckx, Rudi; Herrmann, Ken; Hustinx, Roland; Lassmann, Michael; Wadsak, Wolfgang; Kunikowska, Jolanta

Dierckx, Rudi; Herrmann, Ken; Hustinx, Roland; Lassmann, Michael; Wadsak, Wolfgang; Kunikowska, Jolanta.

Afiliación

Dierckx R; Department of Nuclear Medicine and Molecular Imaging, University of Groningen, University Medical Centre Groningen, Groningen, The Netherlands.
Herrmann K; Department of Nuclear Medicine, University of Duisburg-Essen, and German Cancer Consortium (DKTK)-University Hospital Essen, Essen, Germany.
Hustinx R; Division of Nuclear Medicine and Oncological Imaging, University Hospital of Liège, Belgium and GIGACRC In Vivo Imaging, University of Liège, Liège, Belgium.
Lassmann M; Department of Nuclear Medicine, University Würzburg, Würzburg, Germany.
Wadsak W; Division of Nuclear Medicine, Department of Biomedical Imaging and ImageGuided Therapy, Medical University of Vienna, Vienna, Austria.
Kunikowska J; Center for Biomarker Research in Medicine (CBmed GmbH), Graz, Austria.

Eur J Nucl Med Mol Imaging ; 50(2): 630, 2023 Jan.

Article en En | MEDLINE | ID: mdl-36374354

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Banco de datos: MEDLINE Tipo de estudio: Risk_factors_studies Idioma: En Revista: Eur J Nucl Med Mol Imaging Asunto de la revista: MEDICINA NUCLEAR Año: 2023 Tipo del documento: Article País de afiliación: Países Bajos

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google